Barbacci EG - Search Results

1

The structural basis for the specificity of epidermal growth factor and heregulin binding.

Barbacci EG, Guarino BC, Stroh JG, Singleton DH, Rosnack KJ, Moyer JD, Andrews GC. Barbacci EG, et al. J Biol Chem. 1995 Apr 21;270(16):9585-9. doi: 10.1074/jbc.270.16.9585. J Biol Chem. 1995. PMID: 7721889 Free article.

2

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.

Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, Moyer JD, DiOrio CI, Barbacci EG, et al. Schnur RC, et al. Among authors: barbacci eg. J Med Chem. 1995 Sep 15;38(19):3806-12. doi: 10.1021/jm00019a010. J Med Chem. 1995. PMID: 7562911

3

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, DiOrio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P. Moyer JD, et al. Among authors: barbacci eg. Cancer Res. 1997 Nov 1;57(21):4838-48. Cancer Res. 1997. PMID: 9354447

4

Binding of benzoquinoid ansamycins to p100 correlates with their ability to deplete the erbB2 gene product p185.

Miller P, Schnur RC, Barbacci E, Moyer MP, Moyer JD. Miller P, et al. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1313-9. doi: 10.1006/bbrc.1994.1847. Biochem Biophys Res Commun. 1994. PMID: 7912926

5

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ. Pollack VA, et al. Among authors: barbacci eg. J Pharmacol Exp Ther. 1999 Nov;291(2):739-48. J Pharmacol Exp Ther. 1999. PMID: 10525095

6

Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.

Tzahar E, Moyer JD, Waterman H, Barbacci EG, Bao J, Levkowitz G, Shelly M, Strano S, Pinkas-Kramarski R, Pierce JH, Andrews GC, Yarden Y. Tzahar E, et al. Among authors: barbacci eg. EMBO J. 1998 Oct 15;17(20):5948-63. doi: 10.1093/emboj/17.20.5948. EMBO J. 1998. PMID: 9774339 Free PMC article.

7

The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.

Barbacci EG, Pustilnik LR, Rossi AM, Emerson E, Miller PE, Boscoe BP, Cox ED, Iwata KK, Jani JP, Provoncha K, Kath JC, Liu Z, Moyer JD. Barbacci EG, et al. Cancer Res. 2003 Aug 1;63(15):4450-9. Cancer Res. 2003. PMID: 12907618

8

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.

Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, DiOrio CI, Barbacci EG, Miller PE, et al. Schnur RC, et al. Among authors: barbacci eg. J Med Chem. 1995 Sep 15;38(19):3813-20. doi: 10.1021/jm00019a011. J Med Chem. 1995. PMID: 7562912

9

Identification and characterization of an ecto-ATPase activity in rat Sertoli cells.

Barbacci E, Filippini A, De Cesaris P, Ziparo E. Barbacci E, et al. Biochem Biophys Res Commun. 1996 May 15;222(2):273-9. doi: 10.1006/bbrc.1996.0734. Biochem Biophys Res Commun. 1996. PMID: 8670195

10

TNF-alpha induces surface modifications in mouse Sertoli cells: physiopathological implications.

Ziparo E, Riccioli A, Filippini A, De Cesaris P, Barbacci E. Ziparo E, et al. Ital J Anat Embryol. 1995;100 Suppl 1:553-62. Ital J Anat Embryol. 1995. PMID: 11322336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters